A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER-positive, HER2 negative Advanced Breast Cancer (SERENA-1)

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

University of Colorado Hospital

Study ID

Protocol Number: 18-2654

More information available at ClinicalTrials.gov: NCT03616587

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers